Jeffrey Cadeddu, MD
Urology · Dallas, TXNPI 1528037058
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (28.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Axogen at 31.3% of the total.
Across 73 payments — averaging $207.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axogen$5K
- Intuitive Surgical$5K
- Integra Lifesciences Corporation$2K
- Stryker$2K
- Myriad Genetic Laboratories, Inc.$489
- Medtronic$376
- plus $1K from 15 others
Across 1 payment — averaging $28,479 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Histosonics, Inc.$28K
What the payments were for
- Consulting fees$4,25028%
- Speaking & faculty fees$2,00013%
- Travel & lodging$2,59317%
- Food & beverage$4,29128%
- Education$150%
- Other$1,98313%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axogen | 6 | $4,741 |
| Intuitive Surgical | 22 | $4,719 |
| Integra Lifesciences Corporation | 3 | $2,005 |
| Stryker | 16 | $1,597 |
| Myriad Genetic Laboratories, Inc. | 3 | $489 |
| Medtronic(2 entities) | 3 | $376 |
| Angiodynamics, Inc. | 1 | $303 |
| Boston Scientific | 3 | $196 |
| Teleflex LLC | 1 | $161 |
| Conmed Corporation | 1 | $147 |
| Blue Earth Diagnostics | 1 | $100 |
| Urogen Pharma, Inc. | 3 | $57 |
| Levita Magnetics International Corp. | 1 | $54 |
| Innovation Technologies Inc | 2 | $49 |
| Johnson & Johnson | 1 | $27 |
| Cook Medical LLC | 1 | $26 |
| Olympus America Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $18 |
| Pfizer | 1 | $15 |
| Coloplast | 1 | $14 |
| Antares Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AXOGUARD$8,978
- AXOGUARD HA+ NERVE PROTECTOR$4,489
- AxoGuard Nerve Cap$4,489
- Da Vinci Surgical System$4,262
- INTEGRA$1,983
- 1788$989
- Prolaris$489
- INTERSTIM$279
- AIRSEAL$147
- CHROMOPHARE F300$141
- POSLUMA$100
How this compares
$15,131 in reported general payments places this provider in the 80th percentile of 878 urology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Finasteride | 37 | $715 |
| Tamsulosin Hcl | 54 | $632 |
| Ciprofloxacin Hcl | 14 | $108 |
| Levofloxacin | 13 | $42 |
| Tramadol Hcl | 28 | $33 |
Paid to pharmacies, not to this prescriber.
Other urology in Dallas
- Allen MoreyDallas$914K
- Vitaly MargulisDallas$555K
- Yair LotanDallas$371K
- Claus RoehrbornDallas$169K
- Samantha NealonDallas$89K
- Maia VandykeDallas$79K
- Gary LemackDallas$62K
- Brian LangfordDallas$57K
- Jonathan SeamanDallas$55K
- Andrew von EschenbachMontgomery$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.